Schmidt-Wolf IG - Search Results

1

CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study.

Gorschlüter M, Glasmacher A, Sarazin S, Hackbarth F, Hoebert E, Orlopp K, Schmidt-Wolf IG, Mey U. Gorschlüter M, et al. Leuk Lymphoma. 2007 Mar;48(3):506-12. doi: 10.1080/10428190601094347. Leuk Lymphoma. 2007. PMID: 17454590

2

Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.

Glasmacher A, Molitor E, Hahn C, Bomba K, Ewig S, Leutner C, Wardelmann E, Schmidt-Wolf IG, Mezger J, Marklein G, Sauerbruch T. Glasmacher A, et al. Leukemia. 1998 Sep;12(9):1338-43. doi: 10.1038/sj.leu.2401137. Leukemia. 1998. PMID: 9737680

3

Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia.

Müller M, Scheffold C, Lefterova P, Huhn D, Neubauer A, Schmidt-Wolf IG. Müller M, et al. Leuk Lymphoma. 1998 Oct;31(3-4):335-41. doi: 10.3109/10428199809059226. Leuk Lymphoma. 1998. PMID: 9869197

4

Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.

Glasmacher A, Hahn C, Molitor E, Sauerbruch T, Schmidt-Wolf IG, Marklein G. Glasmacher A, et al. Mycoses. 1999;42(5-6):395-402. doi: 10.1046/j.1439-0507.1999.00476.x. Mycoses. 1999. PMID: 10536431

5

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.

Glasmacher A, Hahn C, Leutner C, Molitor E, Wardelmann E, Losem C, Sauerbruch T, Marklein G, Schmidt-Wolf IG. Glasmacher A, et al. Mycoses. 1999;42(7-8):443-51. doi: 10.1046/j.1439-0507.1999.00505.x. Mycoses. 1999. PMID: 10546485

6

Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.

Glasmacher A, Hahn C, Molitor E, Marklein G, Sauerbruch T, Schmidt-Wolf IG. Glasmacher A, et al. Mycoses. 1999;42(11-12):591-600. doi: 10.1046/j.1439-0507.1999.00518.x. Mycoses. 1999. PMID: 10680434 Clinical Trial.

7

Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9.

Ziske C, Märten A, Schöttker B, Buttgereit P, Schakowski F, Gorschlüter M, von Rücker A, Scheffold C, Chao N, Sauerbruch T, Schmidt-Wolf IG. Ziske C, et al. Mol Ther. 2001 Jan;3(1):54-60. doi: 10.1006/mthe.2000.0230. Mol Ther. 2001. PMID: 11162311 Free article.

8

A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.

Schakowski F, Gorschlüter M, Junghans C, Schroff M, Buttgereit P, Ziske C, Schöttker B, König-Merediz SA, Sauerbruch T, Wittig B, Schmidt-Wolf IG. Schakowski F, et al. Mol Ther. 2001 May;3(5 Pt 1):793-800. doi: 10.1006/mthe.2001.0322. Mol Ther. 2001. PMID: 11356084 Free article.

9

Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.

Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Schmidt-Wolf I, Helmstaedter C, Fliessbach K, Deckert M, Van Roost D, Fimmers R, Bode U, Klockgether T. Schlegel U, et al. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):118-22. doi: 10.1136/jnnp.71.1.118. J Neurol Neurosurg Psychiatry. 2001. PMID: 11413277 Free PMC article.

10

Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.

Gorschlüter M, Ziske C, Glasmacher A, Schmidt-Wolf IG. Gorschlüter M, et al. Clin Cancer Res. 2001 Aug;7(8):2195-204. Clin Cancer Res. 2001. PMID: 11489792 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters